BLASI, FRANCESCO BRUNO ARTURO
BLASI, FRANCESCO BRUNO ARTURO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Nutritional outcomes in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor: A 24-month real-world study
2026 G. Alicandro, L. Zazzeron, V. Visciola, A. Bulfamante, A. Biffi, F. Corti, A. Gramegna, F. Blasi, V. Daccò
Bronchiectasis and sinonasal diseases: a narrative review
2025 E. Simonetta, A. De Angelis, M.S. Silani, V. Polelli, M. Nigro, A. Stainer, F. Amati, A. Gramegna, F. Pirola, G. Mercante, F. Blasi, L. Malvezzi, S. Aliberti
Cystic Fibrosis
2025 S. Misuraca, A. Gramegna, F. Blasi
Pneumonia
2025 I. Barone, F. Blasi
How do climate conditions and urbanisation impact nontuberculous mycobacterial infections? An Italian nationwide case–control study
2025 P. Faverio, L. Del Castello, M. Spotti, P. Rebora, E.C. Maggioni, R. Salerno, A. Perotto, F. Luppi, F.R. Bertuccio, S. Reale, V. Fornari, F. Gozzi, B. Granozzi, F.L. Dente, F. Mariotti, J. Simonetti, G. Gualano, N. Riccardi, M. Ferrarese, L.R. Codecasa, G. Sotgiu, A. Gori, A. Gramegna, M. Ori, E. Simonetta, F. Blasi, S. Aliberti
Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection
2025 C. Lanfranchi, G. Alicandro, L. Cariani, B.S. Orena, A. Gramegna, C. Rizza, F. Blasi, V. Daccò
Rationale and design of the Pneumococcal Pneumonia Epidemiology, Urine Serotyping and Mental Outcomes (PNEUMO) study Europe
2025 C. Prat-Aymerich, L. Hessels, D. Karssen, K.D. Johnson, S. Hullegie, R. Jahja, J. Rodriguez-Baño, B. François, F. Blasi, J.D. Chalmers, G. Barten-Neiner, S. Franch, C. Roberts, M. Ruggieri, T.D. Swarthout, T. Weiss, H. Van Werkhoven, M. Bonten
Critical Issues in the Management of CRMS/CFSPID Children: A National Real‐World Survey
2025 V. Terlizzi, C. Fevola, S. Presti, L. Claut, M. Ambroni, M.A. Calderazzo, I. Esposito, B. Fabrizzi, G. Leonetti, M. Lombardo, M. Maschio, N. Palladino, F. Pauro, G. Pisi, P. Ripani, M. Ros, N. Rotolo, D. Salvatore, A. Sepe, L. Termini, S. Timpano, P. Troiani, P. Vitullo, M. Zanda, F. Blasi, C. Castellani
Lung disease in never-smokers with severe α1 -antitrypsin deficiency: the EARCO Registry
2025 C. Premuda, C. Aljama, G. Granados, I. Ferrarotti, A.G. Corsico, A.M. Turner, M. Torres-Duran, H. Tanash, C. Rodríguez-García, J.S. Jensen, M. Mantero, F. Blasi, M. Miravitlles, M. Barrecheguren, C. Esquinas
Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant
2025 C. Pastorino, L. Menta, E. Pesce, M. Lena, V. Tomati, V. Capurro, M. Di Duca, V. Terlizzi, A. Gramegna, F. Blasi, C. Castellani, S. Cappato, F. Zara, N. Pedemonte, R. Bocciardi
Neutrophil-derived biomarkers in bronchiectasis: identifying a common therapeutic target
2025 J.D. Chalmers, M.A. Mall, K.G. Nielsen, A.B. Chang, S. Aliberti, F. Blasi, B. Korkmaz, N. Lorent, C.C. Taggart, M.R. Loebinger
Dealing With Antibiotic Prophylaxis in Lung Transplantation in the Era of Multidrug Resistance: The Milano Algorithm
2025 A. Lombardi, D. Mangioni, G. Renisi, J. Fumagalli, L. Morlacchi, L. Rosso, A. Palleschi, V. Rossetti, M. Panigada, C. Abbruzzese, L. Cariani, A. Callegaro, M. Nosotti, F. Blasi, G. Grasselli, A. Bandera
Effectiveness of elexacaftor/tezacaftor/ivacaftor therapy in children and adolescents with cystic fibrosis and normal spirometry
2025 G. Alicandro, V. Terlizzi, L. Zazzeron, D. Dolce, L. Cariani, A. Fiandaca, S. Campana, A. Terminiello, D. Innocenti, F. Blasi, V. Daccò
The role of screening for connective tissue diseases in bronchiectasis: an observational study
2025 A. Stainer, M. Nigro, A. Gramegna, E. Simonetta, F. Amati, V. Polelli, A. Tramontano, S. Misuraca, L.C. Morlacchi, F. Blasi, S. Aliberti
Recommendations on PCV20 vaccine in adults and at-risk populations
2025 G. Sotgiu, M. Puci, M. Bartoletti, F. Blasi, P. Bonanni, S. Aliberti
Severe Asthma and Sleep Disorders: A Severe Asthma Network Italy (SANI) Registry Analysis
2025 S. Ferri, V. Marzio, E. Cavaglià, N. Valli, V. Bagnardi, C. Oriecuia, I. Sala, C. Cardini, C. Sirena, G. Paoletti, F. Blasi, P. Paggiaro, G. Canonica, E. Heffler
ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up
2025 L. Pini, M. Caminati, M. Maule, D. Bagnasco, B. Beghè, B. Bondi, F. Braido, P. Cameli, C. Caruso, C. Crimi, Y. El Masri, J. Giordani, G. Guarnieri, M. Latorre, A. Mastrototaro, F. Menzella, C. Micheletto, A. Pini, S. Piras, A. Spanevello, A. Vianello, D. Visca, M. Zappa, M. Zurlo, P. Paggiaro, F. Blasi, G.W. Canonica, G. Senna, R. Benoni
Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)
2025 J. Pollock, E. Polverino, R. Dhar, K. Dimakou, L. Traversi, A. Bossios, C. Haworth, M.R. Loebinger, A. De Soyza, M. Vendrell, P.R. Burgel, P. Mertsch, M.J. Mcdonnell, S. Skgrat, L. Maiz-Carro, O. Sibila, M. Van Der Eerden, P. Kauppi, A.T. Hill, R. Wilson, B. Milenkovic, R. Menéndez, M. Murris, M.L. Crichton, S. Borecki, D. Obradovic, M. Irfan, V. Eshenkulova, A. Nowinski, A. Amorim, A. Torres, N. Lorent, T. Welte, F. Blasi, E. Van Braeckel, J. Altenburg, M. Shteinberg, W. Boersma, J.S. Elborn, S. Aliberti, F.C. Ringshausen, P. Goeminne, J.D. Chalmers
Bispecific T-cell engagers-induced interstitial lung disease: two case reports confirmed by transbronchial lung cryobiopsy
2025 M. Morviducci, F. Maraz, C. Ravaglia, S. Petrarulo, A. Dubini, M. Costantini, D. Diano, F. Blasi, P. Palange, S. Piciucchi, V. Poletti
Limited impact of Elexacaftor/Tezacaftor/Ivacaftor on CPET outcomes in an Italian cohort of people with cystic fibrosis: reinforcing the essential role of exercise training
2025 M. Retucci, A. Gramegna, S. Gambazza, M. Santambrogio, G. Putti, A. Mariani, M.C. Russo, M. Vicenzi, V. Daccò, F. Blasi